Sort
40,608 grants matching “prostate cancer”
Defining mechanisms underlying C9orf72-associated frontotemporal dementia with C. elegans and mammalian models
$745,651Robert G Kalb · Northwestern University At Chicago · R01 · FY2023 · NS
Systems analysis of aggressive prostate cancer pathology
$745,463James Christopher Costello · University Of Colorado Denver · U01 · FY2020 · CA
Ultrasound imaging and local drug delivery in tumors
$745,283Katherine W Ferrara · University Of California At Davis · R01 · FY2010 · CA
An Open-Labeled, Single Arm Phase 2 Efficacy and Safety Study of REM-001 Photodynamic Therapy (PDT) for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)
$745,259Dennis Brown · Kintara Therapeutics, Inc. · R44 · FY2024 · CA
Ultrasound imaging and local drug delivery in tumors
$745,185Katherine W Ferrara · University Of California At Davis · R01 · FY2009 · CA
Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer
$745,146Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer (mCRPC)
$745,050Aaron D Schuler · Syntrix Biosystems, Inc. · R44 · FY2024 · CA
NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
$745,015Norman Wolmark · Nrg Oncology Foundation, Inc. · U10 · FY2018 · CA
Onco-primary care networking to support TEAM-based care - the ONE TEAM Study
$744,941Kevin Charles Oeffinger · Duke University · R01 · FY2023 · CA
A Novel Therapeutic that Harnesses Microtubules to Promote Cavernous Nerve Regeneration after Radical Prostatectomy
$744,817Lisa Ann Baker · Microcures, Inc. · R42 · FY2022 · DK
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients
$744,686Jada Gabrielle Hamilton · Sloan-Kettering Inst Can Research · U01 · FY2023 · CA
Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women
$744,389Joan M Lappe · Creighton University · R01 · FY2012 · CA
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer
$744,376Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Single Molecule Fiber Arrays for the Detection of Low Abundance Proteins
$743,891David C Duffy · Twin Lights Bioscience, Inc. · R44 · FY2011 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial
$743,860Mona N. Fouad · University Of Alabama At Birmingham · N01 · FY2011 · CA
Stroger Hospital of Cook County, MBCCOP
$743,820Thomas Lad · Hektoen Institute For Medical Research · U10 · FY2013 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$743,717David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies
$743,574Yoshihiro Izumiya · University Of California At Davis · R01 · FY2020 · CA
DISCOVERY AND DEVELOPMENT OF MITHRAMYCIN ANALOGS FOR PROSTATE CANCER TREATMENT BY DIRECT INHIBITION OF THE ONCOGENIC TRANSCRIPTION FACTOR ERG (TMPRSS
$743,439University Of Kentucky Research Foundation, The · · FY2016 · Department of the Army
Role of Neurotrophins in the Development of the Mammalian Nervous System
$743,429Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Carolina Community Network
$743,292Paul A. Godley · Univ Of North Carolina Chapel Hill · U01 · FY2007 · CA
Southeast Michigan Community Network Program
$743,260Terrance L. Albrecht · Wayne State University · U54 · FY2014 · CA
Carolina Community Network
$743,195Paul A. Godley · Univ Of North Carolina Chapel Hill · U01 · FY2006 · CA
Role of FSH in postmenopausal obesity and breast cancer
$743,147Jennifer Wright Bea · University Of Arizona · R01 · FY2025 · CA
Evaluatiing the accuracy of complex screening or diagnostic procedures
$743,130Binbing Yu · National Institute On Aging · ZIC · FY2012 · AG